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A B S T R A C T
The limited ﬂexibility and time-consuming nature of the genetic manipulation procedures applicable to
Trypanosoma cruzi continue to restrict the functional dissection of this parasite. We hypothesised that trans-
formation eﬃciency could be enhanced if electroporation was timed to coincide with DNA replication. To test
this, we generated epimastigote cultures enriched at the G1/S boundary using hydroxyurea-induced cell-cycle
synchronisation, and then electroporated parasites at various time points after release from the cell-cycle block.
We found a signiﬁcant increase in transformation eﬃciency, with both episomal and integrative constructs,
when cultures were electroporated 1 h after hydroxyurea removal. It was possible to generate genetically
modiﬁed populations in less than 2 weeks, compared to the normal 4–6 weeks, with a 5 to 8-fold increase in the
number of stably transformed clones. This straightforward optimisation step can be widely applied and should
help streamline functional studies in T. cruzi.
The protozoan parasite Trypanosoma cruzi is the causative agent of
Chagas’ disease, an infection endemic throughout Latin America,
causing high levels of morbidity and mortality. There is no vaccine, and
the available drugs can have toxic side-eﬀects, with treatment failures
widely reported. The completion of the T. cruzi genome project pro-
vided a major opportunity to gain new insights into parasite biology,
disease pathogenesis and resistance mechanisms, as well as providing
an improved framework for drug and vaccine development. Although
there has been signiﬁcant progress, the time-consuming nature of T.
cruzi genetic manipulation procedures has been a rate-limiting step [1].
Advances have also been restricted by the absence of RNAi machinery,
which in Trypanosoma brucei, has been exploited to dissect drug-re-
sistance mechanisms at a genome-wide level [2,3]. However, recent
reports on the transfer of CRISPR/cas9 technology to T. cruzi [4–6], and
the possibility of using forward genetics by constructing over-expres-
sion libraries, suggests that high-throughput functional screening ap-
proaches might be applicable to this parasite, if transfection eﬃciency
can be improved. Electroporation of epimastigotes is the only trans-
fection method currently used for genetic modiﬁcation of T. cruzi [1].
However, it is relatively ineﬃcient and the process takes 4–6 weeks to
produce an initial population of transformants. This time-scale is sig-
niﬁcantly lengthened when the aim is to generate null mutants, since
two rounds of transfection have to be undertaken, plus an additional
round when a rescue vector is required [7]. Here we describe a simple
optimization step that enhances T. cruzi transfection eﬃciency, re-
sulting in an increase in the number of transformants generated and a
signiﬁcant reduction in the time required to select a drug-resistant
population.
To explore the eﬀect of the cell-cycle phase on transfection eﬃ-
ciency, we ﬁrst induced exponentially growing T. cruzi epimastigotes to
arrest at the G1/S boundary by incubation with 20mM hydroxyurea
(HU) for 24 h. HU inhibits ribonucleotide reductase, causing depletion
of dNTPs and inhibition of DNA replication [8–11]. Following HU re-
moval, the parasite population was assessed by ﬂow cytometry
(Fig. 1A). Within 6 h, the majority of cells had transitioned from G1 to S
phase, and by 18 h, most had progressed to G2 (Fig. 1B). Epimastigotes
were electroporated with the episomal vector pTREXn-GFP [12] at
various time points after release from the cell-cycle block. We used the
Amaxa Nucleofector (programme X-014) with buﬀer Tb-BSF [13],
conditions we had found to be optimal for T. cruzi. After electropora-
tion, parasites were transferred to 10ml of fresh medium [14] and as-
sessed by ﬂow cytometry 48 h later. Transient transfection eﬃciency
(assessed on the basis of GFP expression) (Fig. 1C and D) was highest in
the parasites electroporated 1 h after the removal of HU (18.4+ 0.6%),
followed by the non-treated population (13.9+2.7%) (p=0.005), and
then those electroporated 6 h (2.3±0.7%) and 18 h (0.4±0.1%) after
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the removal of HU (Fig. 1E).
Following addition of the selective drug G418 (100 μg/ml), we
monitored the outgrowth of stably transformed drug-resistant parasites.
Under selective pressure, replication of mock-transfected parasites
ceased within 7 days (Fig. 2A). Parasites electroporated 1 h after HU
removal displayed rapid outgrowth of drug-resistant transformants, and
were suitable for sub-culturing and expansion within 14 days, a situa-
tion not achieved until week 5 in the case of the non-synchronised
population (Fig. 2A). With parasites transfected 6 and 18 h after HU
removal, the outgrowth of stable transformants took up to 8 weeks. To
assess the eﬃciency of stable transformation, parasites transfected with
pTREXn-GFP were plated by limiting dilution under G418-selection. At
least 200 transformants/μg of DNA were generated when parasites were
transfected 1 h after release from the cell-cycle block, ﬁve times the
number achievable with asynchronised cells (Fig. 2B–D). To investigate
the eﬀect on targeted integration, we used the T. cruzi cell line PpyRE9h
[15], which contains a luciferase gene inserted into a ribosomal locus
(Fig. 2E). These parasites were transfected with a linear DNA construct
designed to integrate at this site to create a chimeric bioluminescent/
ﬂuorescent protein gene and to replace the neomycin phospho-
transferase gene with one that confers resistance to hygromycin [6].
When electroporation was carried out 1 h after HU removal, we found
an eight-fold increase in the number of hygromycin-resistant transfor-
mants, compared to the numbers achievable with asynchronous cells
(Fig. 2F). We were able to demonstrate that transfection had resulted in
targeted insertion, expression of a fusion protein reporter and that the
parasite population was universally ﬂuorescent (Fig. 2G and H).
The HU-mediated cell-cycle synchronisation step improves the
outcome of T. cruzi transfection experiments in two ways; ﬁrst, by in-
creasing the number of transformants generated, and second, by redu-
cing signiﬁcantly the time required to select an exponentially growing
genetically modiﬁed population. HU treatment is known to result in
stalled replication forks [16], which can lead to double-strand breaks
(DSBs) and increased recombination during S phase [17]. Under the
synchronisation conditions used (1 h, 20mM; Fig. 1), no detrimental
eﬀects that were attributable to HU-mediated toxicity were observed,
although we cannot exclude it as a possibility in some instances. In
yeast, HU-treatment has been shown to promote targeted integration
[18]. In T. cruzi, repair of DSBs by non-homologous end-joining is ab-
sent, with homologous recombination being the dominant process in-
volved [4]. Therefore, the enhanced targeted integration that we ob-
serve (Fig. 2E–H) might result from DSBs induced by HU treatment. In
the case of non-integrative transformation, the entry of episomal DNA
into parasites as they are about to transition into S-phase could allow
rapid replication and enhanced stability. At 6 h post-treatment how-
ever, when the majority of parasites will have completed genomic DNA
replication [19], and be on the verge of entry into G2, this eﬀect would
be greatly reduced, with a concomitant drop in transfection eﬃciency.
Whatever the precise mechanism, the procedures described here should
help to streamline functional studies in T. cruzi, and may be more
widely applicable to other protozoa.
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Fig. 2. Eﬀect of hydroxyurea (HU) treatment on the generation of stably transformed Trypanosoma cruzi following transfection with episomal and integrative vectors.
(A) Outgrowth of G418-resistant (100 μg/ml) T. cruzi epimastigotes following incubation in 20mM HU for 24 h, and transfection with pTREXn-GFP (legend to Fig. 1)
at various time points after release from the cell-cycle block. Parasite proliferation, determined at weekly intervals, is presented as the fold increase compared to the
number of cells transfected (experiment in triplicate). (B) Assessing episomal transformation eﬃciency by limiting dilution. Following transfection with pTREXn-
GFP, HU treated parasites were subjected to serial dilution under selective pressure (100 μg/ml G418) in 48 well plates (total volume, 1ml per well). The minimum
number of drug-resistant parasites generated per μg of episomal DNA can be inferred from the wells (highlighted in green) containing drug-resistant parasites 8 weeks
post-transfection (performed in triplicate). (C) DNA was prepared from transfected (T) and non-transfected (NT) parasites and assessed by PCR using primers speciﬁc
to the neomycin phosphotransferase (Neo) gene. (D) Epimastigotes were ﬁxed in 2% paraformaldehyde and imaged on a Zeiss LSM 510 confocal microscope to
identify those expressing GFP (green). DNA is stained with DAPI (red). (E) Construct used for integrative transformation. Sequences derived from the 3′-end of the
red-shifted luciferase gene LucPpyRE9h and the region upstream of an 18S rRNA gene were arranged to facilitate targeted integration [6], generating a biolumi-
nescent:ﬂuorescent (mNeonGreen) fusion protein gene and conferring hygromycin (Hyg) resistance. (F) Assessing integrative transformation by limiting dilution.
Following transfection, parasites were subjected to serial dilution under selective pressure (100 μg/ml hygromycin). The number of parasites generated per μg of DNA
(performed in triplicate) can be inferred as outlined above. (G) Conﬁrmation of integration using PCR. Primer pairs are colour-coded (see image 2E). (H) Transformed
epimastigotes (23 days post-transfection cultured under continuous hygromycin-selection) imaged by confocal microscopy showing acquisition of ﬂuorescence
(green). DNA is stained with DAPI (red).
F. Olmo et al. Molecular & Biochemical Parasitology 226 (2018) 34–36
36
